US Patent 9,181,544
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
Davidson, Beverly L. and Boudreau, Ryan L. Therapeutic compounds. US Patent 9,181,544 filed February 13, 2012 and issued November 10, 2015. https://ir.uiowa.edu/patents/648